GENEVA, Nov 17: Chemicals present in everyday consumer products are posing an increasingly serious threat to human health and the environment, according to a new United Nations assessment that warns of growing scientific evidence linking exposure to hormonal disruption, cancer, diabetes and reproductive disorders.
The report, prepared by the United Nations Environment Programme (UNEP) and the World Health Organization (WHO), highlights concerns surrounding endocrine-disrupting chemicals (EDCs), which are widely used in products ranging from plastics and personal-care items to medicines, toys, electronics and agricultural pesticides.
The assessment points to the growing understanding of how these substances interfere with the body’s hormonal systems and potentially contribute to a wide range of health complications.
It estimates that the annual health-related economic burden associated with exposure to endocrine-disrupting chemicals exceeds USD 1.1 trillion globally. The figure includes healthcare expenses and productivity losses, indicating that the consequences extend beyond individual patients and place additional pressure on economies and public-health systems.
The report calls for coordinated international action to improve chemical safety, strengthen regulatory oversight and reduce exposure, particularly among vulnerable populations such as pregnant women, infants and children.
It also warns that existing policies and regulations remain fragmented, leaving significant gaps in the monitoring and control of substances used in manufacturing and consumer products.
The latest assessment builds on previous scientific reviews published in 2002 and 2012, incorporating developments in research methods, exposure monitoring and the understanding of health effects.
Growing Scientific Evidence of Health Risks
Endocrine-disrupting chemicals are substances capable of interfering with the body’s endocrine system, which regulates several essential biological functions through hormones.
Hormones influence growth, metabolism, reproduction, brain development, immune responses and other important processes. Any disruption to these systems can potentially affect normal bodily functions.
According to the UN assessment, scientific evidence connecting exposure to these chemicals with human diseases and developmental disorders has strengthened considerably since the previous major review.
Researchers have identified associations with several serious health conditions, including certain cancers, cardiovascular diseases, obesity, type-2 diabetes and metabolic liver disorders.
The report also highlights concerns involving reproductive health, fertility, thyroid function and the development of organs responsible for maintaining hormonal balance.
Exposure during pregnancy and early childhood is considered particularly concerning because these stages involve rapid development of the brain, nervous system and other vital organs.
Prenatal exposure may affect neurological development, while exposure during childhood can influence cognitive abilities and behaviour.
Scientists have also raised concerns about the possibility that certain chemicals may produce effects even at relatively low exposure levels, depending on the substance, timing and duration of contact.
The findings underline the importance of examining not only individual chemicals but also the combined exposure people experience through different products and environmental sources.
Laura Vandenberg, a professor of environmental health sciences at the University of Massachusetts Amherst and one of the lead authors of the report, said scientific understanding of the health effects had advanced substantially compared with the situation in 2012.
The latest findings indicate that researchers now have stronger evidence connecting these substances with adverse health outcomes and environmental damage.
Everyday Products Among Major Exposure Sources
One of the major concerns highlighted in the report is the widespread presence of endocrine-disrupting chemicals in products used regularly by households.
Certain plastics, personal-care products, pharmaceuticals, toys, household materials, electronic equipment and pesticides can contain substances capable of interfering with hormonal activity.
People may come into contact with these chemicals through several pathways, including eating contaminated food, drinking affected water, inhaling airborne particles and absorbing substances through the skin.
Medical procedures may also create exposure through certain devices and materials used in healthcare settings.
Children face additional risks because they frequently put toys and other objects in their mouths or maintain prolonged skin contact with products containing chemical additives.
The report stresses that exposure is not restricted to industrial workers or people living near manufacturing facilities. The widespread use of chemical-containing materials means that ordinary consumer activities can also contribute to contact with these substances.
Plastic products have attracted particular attention because chemical additives are used to provide flexibility, durability, rigidity and resistance to ultraviolet radiation.
These substances help manufacturers achieve specific product characteristics, but concerns arise when chemicals migrate from materials into food, water, household dust or the surrounding environment.
The extent of exposure can vary depending on the type of chemical, manufacturing process, product composition and conditions under which an item is used.
The report therefore calls for better information about the chemicals used in consumer products and improved systems to monitor their movement through the environment and human populations.
More Than 350,000 Chemicals Registered Worldwide
The assessment highlights a major regulatory challenge, noting that more than 350,000 chemicals and chemical mixtures have been registered for production and use globally.
However, the vast majority have not been adequately evaluated for their potential endocrine-disrupting properties.
Although testing programmes have expanded in recent years, researchers say the available scientific information has not consistently resulted in effective regulatory action.
This gap between scientific knowledge and policy implementation remains one of the central concerns identified in the report.
Authorities often face difficulties assessing the safety of substances used across multiple industries because chemical applications vary considerably.
A compound may be used in packaging, electronics, personal-care products or industrial manufacturing, making it necessary to consider different exposure pathways and potential health effects.
The assessment argues that regulatory systems need to become more comprehensive and preventive rather than relying primarily on action after harmful effects have been identified.
It also highlights the need for improved testing methods capable of identifying substances that interfere with hormonal systems.
Better coordination between governments, research institutions, manufacturers and international organisations could help establish consistent safety standards.
Plastic Production Raises Additional Concerns
The report’s findings have renewed attention on chemical additives used in plastic manufacturing and the broader environmental consequences of plastic pollution.
Plastic products often contain multiple additives that provide desired characteristics, but some substances have raised concerns because of their potential effects on human health.
International discussions on a global agreement to address plastic pollution have also included demands for stronger controls on hazardous chemicals used in plastic production.
Environmental organisations have argued that reducing plastic pollution requires attention not only to discarded materials but also to the chemical composition of products throughout their life cycle.
Bjorn Beeler, international coordinator for the International Pollutants Elimination Network, said the assessment strengthens the case for global controls on hazardous substances used in plastics.
He warned that increasing plastic and chemical production could expand exposure unless governments introduce stronger preventive measures.
However, representatives of the chemical industry have argued that restrictions should be based on scientific risk assessments and comprehensive regulatory frameworks.
The American Chemistry Council has maintained that chemical safety is a priority and that existing national and international regulatory systems provide mechanisms for evaluating substances according to their uses and associated risks.
The debate highlights the difficulty of balancing industrial applications with public-health protection.
Manufacturers rely on chemical additives to develop products used across numerous sectors, but the growing evidence of potential harm has increased pressure for more transparent safety assessments.
Economic Burden Estimated at Over USD 1.1 Trillion
Beyond the direct medical consequences, the report draws attention to the substantial economic impact associated with exposure to endocrine-disrupting chemicals.
The estimated annual health-related cost of more than USD 1.1 trillion includes expenses associated with treating health conditions and productivity losses resulting from illness.
These costs demonstrate how chemical exposure can affect individuals, families, healthcare providers and national economies.
People experiencing chronic illnesses may require repeated medical consultations, medication, hospitalisation and long-term treatment.
At the same time, health problems can affect employment, reduce productivity and create additional financial pressure on households.
The UN assessment describes its economic estimate as conservative because it does not account for several wider consequences.
These include contaminated drinking water, biodiversity loss, damage to food production systems and broader environmental and human-rights impacts.
The actual economic burden could therefore be considerably higher when indirect and long-term effects are considered.
The findings also suggest that preventing harmful exposure could provide substantial economic benefits by reducing the need for treatment and limiting productivity losses.
The report argues that governments should consider the financial consequences of regulatory inaction when evaluating policies concerning chemical manufacturing and consumer products.
Pregnant Women and Children Need Greater Protection
The assessment places particular emphasis on protecting populations that may be more vulnerable to the effects of endocrine-disrupting chemicals.
Pregnancy, infancy and childhood are important developmental stages during which exposure to harmful substances can have lasting consequences.
The developing brain, reproductive system and other organs may be particularly sensitive to changes in hormonal activity.
The report therefore recommends stronger safeguards for pregnant women, infants and young children.
It also highlights the need for better information about exposure levels among vulnerable communities and improved monitoring of chemicals in products and the environment.
Children’s toys, food-contact materials and personal-care products require particular attention because they may create repeated opportunities for exposure.
Healthcare professionals and public-health authorities also have an important role in improving awareness of environmental factors that could influence long-term health.
The report suggests that preventive policies should focus on reducing exposure at the population level rather than placing the entire responsibility on individual consumers.
This approach would require stronger manufacturing standards, improved product information and effective enforcement of chemical safety regulations.
UN Calls for Stronger International Cooperation
The WHO and UNEP assessment identifies several areas where governments and international organisations need to strengthen their efforts.
These include improving chemical testing, expanding exposure monitoring, protecting vulnerable groups and introducing more effective regulatory frameworks.
Authorities have also been urged to account for the long-term health and economic costs associated with chemical exposure while developing industrial and environmental policies.
The report stresses that governments should make greater use of available scientific evidence when determining whether chemicals are safe for particular applications.
Another concern involves the replacement of restricted chemicals with substances that have similar structures but have not been adequately tested.
Such substitutions can create a cycle in which one potentially harmful chemical is removed while another with comparable properties enters the market.
Researchers have therefore called for broader assessments that examine the safety of chemical groups and possible alternatives rather than evaluating substances in isolation.
Jacqueline Alvarez, chief of UNEP’s Chemicals and Health Branch, said the latest assessment reflects significant progress in scientific understanding and highlights the growing economic and social costs of failing to address chemical risks.
The report’s authors believe that sufficient evidence already exists to support stronger preventive measures in several areas.
Bethanie Carney Almroth, a professor of ecotoxicology at Sweden’s University of Gothenburg and a UN Special Rapporteur on toxics and human rights, has called for a shift towards preventing harm before it occurs rather than relying on responses after exposure has already affected public health.
A Wider Challenge for Global Public Health
The findings present governments with a growing challenge as chemical production and consumption continue to expand across industries.
Modern economies depend on a wide range of manufactured materials, medicines, electronic equipment, packaging and agricultural products. Ensuring the safety of these products requires continuous scientific evaluation and effective oversight.
The UN assessment highlights the need to integrate chemical safety into broader public-health, environmental and economic planning.
It also demonstrates that the consequences of exposure cannot be addressed by healthcare systems alone. Preventive action must involve manufacturing industries, regulatory agencies, environmental authorities and international institutions.
For developing countries, the challenge may be particularly significant because rapid industrialisation and expanding consumer markets can increase the use of chemical-containing products while regulatory and testing infrastructure may remain limited.
Strengthening laboratory facilities, improving surveillance and establishing transparent product-safety standards will therefore be important steps towards reducing exposure.
The report does not suggest that every product containing chemical additives is necessarily harmful. Instead, it calls for stronger scientific assessment to identify substances that present risks and ensure that their use is appropriately controlled.
Its central message is that public-health protection must begin before harmful exposure occurs.
With more than 350,000 chemicals and mixtures registered globally and many still lacking adequate endocrine-disruption assessments, the findings underline the scale of the task facing policymakers.
The WHO and UNEP have urged countries to use the latest scientific evidence to strengthen regulations, protect vulnerable populations and encourage safer alternatives.
The assessment serves as a warning that chemical safety is not merely an environmental issue but an important component of disease prevention, healthcare planning and long-term human development.